A Hybrid Framework For Drug Response Similarity Opting Machine Learning Approach
Main Article Content
Abstract
Because of the computational complexity of numerous to count multivariate attributes, the medical realm is revolutionized in terms of Diseases, Diagnosis, and Treatment Prediction, putting tremendous emphasis on the consistency of the study. Despite this, many methods such as Clustering and Classification have dominated the day, leaving just a few hairline holes on the road to full productivity. By using advanced K-Means in predicting Drug probability in core characteristics of Patients, our Deep Learning-based solution aims to close these holes. The suggested Methodology focuses on assessing Drug Response Similarities using an improved clustering approach that takes into account sensitive patient characteristics. We conclusively achieved its accuracy on the UCI Patient dataset, with improved Quality Variable outcomes.
Downloads
Metrics
Article Details
Licensing
TURCOMAT publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.